Qube Research & Technologies (QRT)
HQL

Qube Research & Technologies (QRT)’s abrdn Life Sciences Investors HQL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-38,293
Closed -$522K – 4197
2024
Q1 		$522K Buy
38,293
+847
+2% +$11.7K ﹤0.01% 2515
2023
Q4 		$504K Hold
37,446
– – ﹤0.01% 2279
2023
Q3 		$467K Hold
37,446
– – ﹤0.01% 2057
2023
Q2 		$507K Hold
37,446
– – ﹤0.01% 1506
2023
Q1 		$522K Buy
37,446
+21,097
+129% +$302K ﹤0.01% 1555
2022
Q4 		$232K Buy
+16,349
New +$237K ﹤0.01% 1751
2020
Q1 		– Sell
-15,390
Closed -$268K – 1368
2019
Q4 		$268K Buy
+15,390
New +$253K 0.01% 1271

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HQL Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of abrdn Life Sciences Investors (HQL) in Q2 2024, closing a stake of 38,293 shares — an estimated $522K sold.

Qube Research & Technologies (QRT) first reported a position in HQL in Q4 2019 and held it in 7 quarters. The position peaked at $522K in Q1 2024. 75 funds tracked by Wall St. Rank hold HQL as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining abrdn Life Sciences Investors position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 38,293 abrdn Life Sciences Investors shares in Q2 2024, an estimated $522K.
  • Qube Research & Technologies (QRT) first reported a position in abrdn Life Sciences Investors in Q4 2019 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s abrdn Life Sciences Investors position peaked at $522K in Q1 2024.
  • 75 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.